The National Environment Agency has warned of a surge in cases of dengue in coming months. In fact, the number of cases reported so far this year is far exceeding those reported in 2018 and 2017!

With that in mind, how are biotech companies positioned to address this crisis at hand? And where can investors find attractive opportunities within this growing landscape? Michelle Martin invites Dr David Foster, CEO and Managing Director, Island Pharmaceuticals to find out more.